MOH vs. HUM, CNC, BNTX, BAX, STE, ARGX, ILMN, PHG, ALGN, and GMAB
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Humana (HUM), Centene (CNC), BioNTech (BNTX), Baxter International (BAX), STERIS (STE), argenx (ARGX), Illumina (ILMN), Koninklijke Philips (PHG), Align Technology (ALGN), and Genmab A/S (GMAB). These companies are all part of the "medical" sector.
Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.
Humana received 358 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 64.15% of users gave Humana an outperform vote while only 56.93% of users gave Molina Healthcare an outperform vote.
Molina Healthcare has a net margin of 2.99% compared to Humana's net margin of 1.82%. Molina Healthcare's return on equity of 29.86% beat Humana's return on equity.
Molina Healthcare currently has a consensus target price of $396.09, indicating a potential upside of 15.74%. Humana has a consensus target price of $424.50, indicating a potential upside of 38.77%. Given Humana's stronger consensus rating and higher probable upside, analysts clearly believe Humana is more favorable than Molina Healthcare.
In the previous week, Humana had 29 more articles in the media than Molina Healthcare. MarketBeat recorded 61 mentions for Humana and 32 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 0.62 beat Humana's score of 0.34 indicating that Molina Healthcare is being referred to more favorably in the media.
Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.
98.5% of Molina Healthcare shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 1.1% of Molina Healthcare shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Molina Healthcare has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.
Summary
Molina Healthcare and Humana tied by winning 9 of the 18 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
